title: Management of interleukin-2-induced severe bronchoconstriction.
authors.forename: T
authors.initials: T
authors.lastname: Suda
authors.forename: H
authors.initials: H
authors.lastname: Hashizume
authors.forename: Y
authors.initials: Y
authors.lastname: Aoshima
authors.forename: K
authors.initials: K
authors.lastname: Yokomura
authors.forename: J
authors.initials: J
authors.lastname: Sato
authors.forename: N
authors.initials: N
authors.lastname: Inui
authors.forename: Y
authors.initials: Y
authors.lastname: Nakamura
authors.forename: T
authors.initials: T
authors.lastname: Fujisawa
authors.forename: N
authors.initials: N
authors.lastname: Enomoto
authors.forename: K
authors.initials: K
authors.lastname: Chida
mesh_terms: D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D000368:Aged; D000369:Aged, 80 and over; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000730:Androstadienes / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001982:Bronchial Diseases / Q000139:chemically induced* / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D003251:Constriction, Pathologic / Q000139:chemically induced / Q000188:drug therapy; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D005260:Female; D000068298:Fluticasone; D005541:Forced Expiratory Volume / Q000187:drug effects; D006390:Hemangioendothelioma / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D015552:Injections, Intralesional; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011292:Premedication; D000068299:Salmeterol Xinafoate; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000318:Adrenergic beta-Agonists; D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D001993:Bronchodilator Agents; D003692:Delayed-Action Preparations; D007376:Interleukin-2; D000068299:Salmeterol Xinafoate; D000068298:Fluticasone; D000420:Albuterol